Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
Zeina A Yanbeiy, Karen E HansenRheumatology Division, Department of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, WI, USAObjective: Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis. In May 2018, denosumab was approv...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-08-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/denosumab-in-the-treatment-of-glucocorticoid-induced-osteoporosis-a-sy-peer-reviewed-article-DDDT |